BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Topics
»
Disease categories and therapies
» Respiratory
Respiratory
RSS
Fujirebio, Nippon Chemiphar to codevelop antiasthma drug
Nov. 26, 1997
Arzneimittelwerk Dresden prepares new 5-LO inhibitors
Nov. 26, 1997
Dual CysLT1/H1 receptor antagonists described in patent literature
Nov. 25, 1997
New NK1 antagonist from Novartis
Nov. 24, 1997
Accolate now available in Canada
Nov. 21, 1997
RPR redirects development of PDE IV inhibitor
Nov. 21, 1997
New NK3/NK4 antagonist in the pipeline at SKB
Nov. 20, 1997
Extensive preclinical results described for new NK2 antagonist
Nov. 20, 1997
Beclometasone CFC-free MDI for chronic bronchial asthma approved
Nov. 20, 1997
FDA clears first inhaled corticosteroid for young children with asthma
Nov. 18, 1997
Previous
1
2
…
677
678
679
680
681
682
683
684
685
…
732
733
Next